Overview
- New national estimates count 241,400 women and 276,400 men newly diagnosed in 2023, with 228,960 cancer deaths recorded.
- Age-standardized mortality has dropped over 25 years by 21% for women and 31% for men, with the largest declines in stomach and colorectal cancers, which experts attribute to better therapy, prevention and screening.
- About half of new cases involved prostate (79,600), breast (75,900), lung (58,300) or colorectal cancer (55,300), and incidence rates edged down to 418 per 100,000 men and 347 per 100,000 women.
- Roughly 1.7 million people are living with a diagnosis from the past five years, lifetime risk is about 49% for men and 43% for women, and five-year survival ranges from ~10% for pancreatic cancer to ~95% for melanoma and testicular cancer.
- The 15th ‘Krebs in Deutschland’ adds NUTS‑2 regional maps, histology breakdowns and expanded blood-cancer categories, enabled by clinical registry data from 2020 and faster data integration under a 2021 law.